Confirmation of a gene for multiple sclerosis (MS) to chromosome region 19q13.3.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Genetic Counseling

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12150212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple sclerosis: Genomic rewards

  2001cited by this paper
• Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis

  2000cited by this paper
• TNF-α polymorphisms in multiple sclerosis: no association with −238 and −308 promoter alleles, but the microsatellite allele all is associated with the disease in French patients

  2000cited by this paper
• Chromosome 19 locus apolipoprotein C-II association with multiple sclerosis

  1999cited by this paper
• Association of the APOE ε4 allele with disease activity in multiple sclerosis

  1999cited by this paper
• Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families

  1999cited by this paper
• Apolipoprotein E Polymorphism in Multiple Sclerosis

  1998cited by this paper
• Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese patients.

  1997cited by this paper
• Genomewide scan of multiple sclerosis in Finnish multiplex families.

  1997cited by this paper
• A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex

  1996cited by this paper
• A full genome search in multiple sclerosis

  1996cited by this paper
• A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

  1996cited by this paper
• Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results

  1995cited by this paper
• Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease.

  1994cited by this paper
• Chromosome–specific microsatellite sets for fluorescence–based, semi–automated genome mapping

  1994cited by this paper
• Apolipoprotein E polymorphism and Alzheimer's disease.

  1993cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper

• Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort

  2014cites this paper
• Heterogeneity in multiple sclerosis; a bio-marker approach

  2011cites this paper
• A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility.

  2009cites this paper
• Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission

  2008cites this paper
• OCTN genes: Susceptibility genes for autoimmune diseases?

  2007cites this paper
• APOE epsilon variation in multiple sclerosis susceptibility and disease severity

  2006cites this paper
• Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients.

  2005cites this paper
• The endogenous retroviral locus ERVWE1 is a bona fide gene involved in hominoid placental physiology.

  2004cites this paper
• Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis

  2004cites this paper
• Infectious agents and multiple sclerosis--are Chlamydia pneumoniae and human herpes virus 6 involved?

  2003cites this paper